Diclofenac Sodium And Misoprostol
Product manufactured by Actavis Pharma, Inc.
Indications and Purposes
| 1 Indications And Usage Diclofenac Sodium And Misoprostol Delayed-Release Tablets Are Indicated For Treatment Of The Signs And Symptoms Of Osteoarthritis Or Rheumatoid Arthritis In Patients At High Risk Of Developing Nsaid-Induced Gastric And Duodenal Ulcers And Their Complications. For A List Of Factors That May Increase The Risk Of Nsaid-Induced Gastric And Duodenal Ulcers And Their Complications [See Warnings And Precautions (5.2) ]. Diclofenac Sodium And Misoprostol Delayed-Release Tablets Are A Combination Non-Steroidal Anti-Inflammatory And Prostaglandin E 1 Analog Drug Indicated For The Treatment Of Signs And Symptoms Of Osteoarthritis (Oa) Or Rheumatoid Arthritis (Ra) In Patients At High Risk Of Developing Nsaid-Induced Gastric And Duodenal Ulcers And Their Complications ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Diclofenac Sodium |
|
ZINC1281 |
| 2. Misoprostol |
|
ZINC3812913 |